๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
NCT04622319HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer
Daiichi Sankyo
Phase 3
1,600
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2020-12-04
Active, closed
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
NCT04540497IgG4 Related Disease
Amgen
Phase 3
135
Hohhot, Beijing, Guandong, Shangโ€™ai, Shenyang, Wuhan
2020-12-04
Recruiting
CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma
NCT04661020Large B-Cell Lymphoma (LBCL)
Zhejiang University
Phase 2
40
Hangzhou
2020-12-03
Active, closed
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
NCT04434768Acute Stroke
Ever Supreme Bio Technology Co., Ltd.
Phase 1
10
2020-12-02
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
NCT04613596Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc.
Phase 2/3
626
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen
2020-12-02
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
NCT04743479Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm
Changhai Hospital
Observational
5,000
Shanghai
2020-12-01
Recruiting
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)
NCT04664946Ischemic Stroke, Neuroprotection
Hui-Sheng Chen
Not applicable
30
Shenyang
2020-12-01
Active, closed
Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
NCT05007093DTC - Differentiated Thyroid Cancer
Yansong Lin
Phase 2
20
Beijing
2020-12-01
Recruiting
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
NCT04794595Sepsis, Children, Only
Children's Hospital of Fudan University
Observational
90
Shanghai
2020-12-01
Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
NCT07205510Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging
RenJi Hospital
Observational
10,000
Shanghai
2020-12-01
Recruiting
A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
NCT06353672Liver Diseases, Surgery
Zhejiang University
Not applicable
1,000
Hangzhou
2020-12-01
Recruiting
Myocardial Infarction and Periodontitis: Periodontal Health Intervention.
NCT06745141Acute Myocardial Infarction (AMI), Periodontal Disease
Shanghai 10th People's Hospital
Not applicable
100
Shanghai
2020-12-01
Recruiting
OH2 Injection in Combination With HX008 for Melanoma.
NCT04616443Melanoma
Binhui Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2020-12-01
Active, closed
Postoperative Thrombosis Prevention in Patients With CD
NCT04486859Cushing Disease, DVT, Pulmonary Embolism
Huashan Hospital
Not applicable
206
Fuzhou, Guangzhou, Wuhan, Shanghai, Chengdu, รœrรผmqi, Beijing
2020-12-01
Recruiting
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
NCT04858724IgA Nephropathy
Ruijin Hospital
Observational
2,000
Shanghai
2020-12-01
Recruiting
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
NCT04664933Stroke, Ischemic, Intravascular Thrombosis, Mechanical Thrombectomy
Hui-Sheng Chen
Not applicable
30
Shenyang
2020-12-01
Recruiting
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT05620095Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Beijing, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu, Hangzhou
2020-12-01
Recruiting
Cohort Study of Inpatients and Outpatient Patients With Cerebral Small Vessel Disease
NCT05985213Cerebral Small Vessel Diseases
Shanghai Yueyang Integrated Medicine Hospital
Observational
1,078
Shanghai
2020-12-01
Recruiting
Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC
NCT04615143Recurrent Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
80
Guangzhou
2020-12-01
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital
Observational
40
Shanghai
2020-12-01
Recruiting
Relationship Between "FODMAPs" and "GVHD"
NCT04660487Graft Versus Host Disease
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2020-12-01
Recruiting
PUMCH Dementia Longitudinal Cohort Study
NCT05023564Dementia, Dementia, Vascular, Dementia With Lewy Bodies, Dementia, Mixed
Peking Union Medical College Hospital
Observational
20,000
Beijing
2020-12-01
Recruiting
National Longitudinal Cohort of Hematological Diseases
NCT04645199Multiple Myeloma, Acute Myeloid Leukemia, Hemophilia, Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China
Observational
2,300
Tianjin
2020-12-01
Active, closed
Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL
NCT04624958Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma
Sun Yat-sen University
Phase 2
42
Guangzhou
2020-12-01
By invitation
ORIF Versus CRIF of Completely Displaced and Rotated Lateral Condylar Fractures of the Humerus in Children
NCT04640727Humeral Fractures
Guangzhou Women and Children's Medical Center
Observational
100
Guangzhou
2020-12-01
Active, closed
Clinical Cohort Study of DHA in Neurodevelopmental Disorders
NCT05841927Autism or Autistic Traits
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2020-12-01
Active, closed
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT04516616Uterine Cervical Neoplasm, Uterine Cervical Cancer, Cervical Cancer
Huazhong University of Science and Technology
Phase 2
85
Wuhan
2020-12-01
Not yet open
A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer
NCT04616040Esophageal Cancer
Peking University
Observational
1,030
Beijing
2020-12-01
Recruiting
Safety and Efficacy Evaluation of ฮฒ-globin Restored Autologous Hematopoietic Stem Cells in ฮฒ-thalassemia Major Patients
NCT05745532ฮฒ-thalassemia
Shenzhen Hemogen
Phase EARLY_PHASE1
10
Shenzhen
2020-12-01
Recruiting
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201Schizophrenia
China Medical University Hospital
Phase 2
90
2020-11-30
Active, closed
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
NCT04576455Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche
Phase 2
303
Changchun, Guangzhou, Linyi, Nanchang, Shanghai, Tianjin, Wuhan, Xi'an
2020-11-27
Active, closed
Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma
NCT04666090Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
42
Hangzhou
2020-11-23
Active, closed
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
NCT04639986Metastatic Breast Cancer
Gilead Sciences
Phase 3
331
Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2020-11-23
Recruiting
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
NCT06375798Breast Cancer, HER2-negative Breast Cancer
Hebei Medical University Fourth Hospital
Observational
620
Shijiazhuang
2020-11-19
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
Eli Lilly and Company
Phase 1
260
2020-11-19
Recruiting
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
NCT05173246Esophageal Small Cell Carcinoma
Sun Yat-sen University
Phase 2
43
Guangzhou
2020-11-17
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Beijing, Guangzhou, Changchun, Xi'an
2020-11-16
Active, closed
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
NCT04611997Gastric Cancer, Lymph Node Metastases
Fujian Medical University
Phase 3
240
Fuzhou
2020-11-16
Not yet open
IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
NCT04599543Acute Myeloid Leukemia
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2020-11-15
Not yet open
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
NCT04609241Relapsed and/or Refractory Acute Lymphoblastic Leukemia, Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma
Zhejiang University
Phase EARLY_PHASE1
72
Hangzhou
2020-11-15
Recruiting
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
NCT04512534Peripheral T-cell Lymphoma
Fudan University
Phase 2
51
Shanghai
2020-11-13
Recruiting
EUS Guided Portal-systemic Pressure Gradient Measurement
NCT04633356Portal Hypertension, Cirrhosis
Chinese University of Hong Kong
Phase 1/2
30
Hong Kong
2020-11-12
Active, closed
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
NCT04644068Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer
AstraZeneca
Phase 1/2
702
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Harbin, Jining
2020-11-12
Recruiting
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT06219083Cancer, Chemoradiotherapy, Nutrition, Healthy, Oncology
Xiaoqin Luo
Observational
1,538
Xi'an
2020-11-12
Recruiting
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
NCT04559243Non-valvular Atrial Fibrillation, Embolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
579
Jinan, Shanghai, Mianyang, Wenzhou
2020-11-12
Active, closed
Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy
NCT04513418Esophageal Neoplasms
Hecheng Li M.D., Ph.D
Phase 3
244
Shanghai, Hangzhou, Ningbo
2020-11-10
Active, closed
Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer
NCT04593615Gastric Cancer, Surgery
Fujian Medical University
Not applicable
1,070
Fuzhou
2020-11-10
Active, closed
A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors
NCT04606472Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
60
Beijing, Chongqing, Xiamen, Zhengzhou, Wuhan, Shanghai, Chengdu
2020-11-10
Active, closed
The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer
NCT07638878Lung Cancer (Locally Advanced or Metastatic)
Guangzhou Medical University
Observational
30
Guangzhou
2020-11-06
Active, closed
Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT04606433Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
47
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shanghai, Tianjin, Hangzhou
2020-11-04
Active, closed
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
NCT04512235AL Amyloidosis
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Recruiting
Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF
NCT04533295Repeated Implantation Failure
Huazhong University of Science and Technology
Not applicable
771
Wuhan
2020-11-02
Recruiting
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
NCT04229966Epidural Hematoma, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Observational
2,000
Shanghai
2020-11-02
By invitation
The Efficacy of Sequential RT After Triple Therapy for uHCC
NCT07052448Hepatocellular Carcinoma
Fujian Provincial Hospital
Observational
35
Fuzhou
2020-11-01
Recruiting
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
NCT05080010Retinoblastoma
Sun Yat-sen University
Phase 3
500
Guangzhou
2020-11-01
Recruiting
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies
NCT04532281Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma of Soft Tissue
Zhejiang University
Phase EARLY_PHASE1
120
Hangzhou
2020-11-01
Recruiting
CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies
NCT04603872Multiple Myeloma in Relapse, Multiple Myeloma, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory
Zhejiang University
Phase EARLY_PHASE1
120
Hangzhou
2020-11-01
Recruiting
Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation
NCT04595864Hepatocellular Carcinoma, Liver Transplantation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
40
Nanjing
2020-11-01
Active, closed
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
NCT04517214Nasopharyngeal Carcinoma
Fudan University
Phase 2
100
Shanghai
2020-11-01
Recruiting
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
NCT04770207Hepatocellular Carcinoma, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
100
Guangzhou
2020-11-01
Recruiting
Surgical Intervention for Refractory Granulomatous Lobular Mastitis
NCT04637711Refractory Granulomatous Lobular Mastitis
Wuhan University
Not applicable
300
Wuhan
2020-11-01
Active, closed
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
NCT04524871Advanced Liver Cancers
Hoffmann-La Roche
Phase 1/2
518
Beijing, Shanghai
2020-11-01
Recruiting
Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
NCT04602338Heart Failure, Diastolic, Multicenter Study
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2020-11-01
Recruiting
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies
NCT04532203Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
Zhejiang University
Phase EARLY_PHASE1
72
Hangzhou
2020-11-01
Recruiting
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
NCT04501718Recurrent Medulloblastoma
Beijing Sanbo Brain Hospital
Phase 2
44
Beijing
2020-10-28
Active, closed
Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)
NCT07204327Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Observational
1,136
Nanjing
2020-10-28
Recruiting
TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NCT06487663Hepatocellular Carcinoma Non-resectable, Cholangiocarcinoma Non-resectable, Liver Metastases, Liver Malignant Tumors
Tianjin Medical University Cancer Institute and Hospital
Not applicable
40
Tianjin
2020-10-27
Active, closed
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
CG Oncology, Inc.
Phase 3
190
2020-10-27
Recruiting
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT04586478Non-Hodgkin's Lymphoma
Juventas Cell Therapy Ltd.
Phase 2
60
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Jinan, Shanghai, Chengdu
2020-10-26
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Xi'an, Jinhua, Ningbo
2020-10-25
Recruiting
Toripalimab Combined With CAV/IE Regimen
NCT04589741Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2
134
Guangzhou
2020-10-23
Active, closed
Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
NCT04454437Metastatic Triple-negative Breast Cancer
Gilead Sciences
Phase 2
80
Beijing, Shenyang, Hangzhou, Changchun, Changsha, Chengdu, Chongqing, Guangzhou
2020-10-23
Active, closed
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
NCT04581473Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma
CARsgen Therapeutics Co., Ltd.
Phase 1/2
192
Hefei, Beijing, Fuzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Nanjing
2020-10-23
Active, closed
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
NCT04464226Cancer
Bayer
Phase 3
402
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou, Shenzhen
2020-10-20
Active, closed
Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
NCT04550260Esophageal Squamous Cell Carcinoma
AstraZeneca
Phase 3
640
Anyang, Beijing, Bengbu, Changsha, Changzhi, Chengdu, Chongqing, Fuzhou
2020-10-19
Recruiting
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
NCT05010343Localized Prostate Cancer
Shanghai Proton and Heavy Ion Center
Phase 2
140
Shanghai
2020-10-15
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
Beijing, Guiyang, Hunan, Jinan, Shanghai, Suzhou, Tianjin, Xi'an
2020-10-15
Recruiting
Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
NCT07184827Recurrent Urinary Tract Infections in Women
TCM Biotech International Corp.
Phase 3
348
2020-10-14
Recruiting
Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
NCT04646759Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
516
Guangzhou
2020-10-14
Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
NCT04917302Schizophrenia
China Medical University Hospital
Phase 2
60
2020-10-13
Active, closed
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
NCT04538664Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
308
Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou
2020-10-13
Recruiting
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
NCT06849063Pancreatic Cancer
Yu Shi
Observational
200
Shenyang
2020-10-09
Recruiting
Assess the Risk of Cerebrovascular Disease
NCT04443439Cerebrovascular Disease
Tang-Du Hospital
Observational
100
Xi'an
2020-10-09
Active, closed
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
NCT04546009Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche
Phase 3
992
Anyang, Baoding, Beijing, Bengbu, Changchun, Changsha, Fujian, Guangzhou
2020-10-09
Recruiting
MRE for Diagnosis of Pancreatic Masses
NCT06526442Pancreatic Neoplasm, Magnetic Resonance Imaging
Yu Shi
Observational
200
Shenyang
2020-10-09
Active, closed
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
NCT04434092Paroxysmal Nocturnal Hemoglobinuria
Hoffmann-La Roche
Phase 3
210
Beijing, Guangzhou, Hangzhou, Nanjing, Nantong, Shanghai, Wuhan
2020-10-08
Active, closed
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
NCT04529772Diffuse Large B-Cell Lymphoma
Acerta Pharma BV
Phase 3
611
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Luoyang
2020-10-08
Recruiting
Assessment System for Sarcopenia Based on Ultrasonographic Data
NCT06199856Sarcopenia, Ultrasound
West China Hospital
Observational
1,500
Chengdu
2020-10-01
Active, closed
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
NCT04484623Multiple Myeloma
GlaxoSmithKline
Phase 3
302
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Jiangsu, Nanchang, Shenyang
2020-10-01
Recruiting
Screening for Early Gastric Cancer in Shaanxi Province
NCT05291728Early Gastric Cancer
Second Affiliated Hospital of Xi'an Jiaotong University
Observational
12,500,000
Xi'an
2020-10-01
Recruiting
China Imaging-based Biobank of Cerebral Small Vessal Diseases
NCT04962295Cerebral Small Vessel Diseases
Peking University Third Hospital
Observational
10,000
Beijing
2020-10-01
Recruiting
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
NCT06599346Mucositis, Hematopoietic Stem Cell Transplantation, Chemotherapy-Induced Mucositis, Radiation-Induced Mucositis
The General Hospital of Western Theater Command
Not applicable
120
Chengdu
2020-10-01
Active, closed
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
NCT04521686Cholangiocarcinoma, Chondrosarcoma, Glioma, Any Solid Tumor
Eli Lilly and Company
Phase 1
200
2020-10-01
Recruiting
Study of Myasthenic Crisis in China
NCT04837625Myasthenia Gravis, Myasthenic Crisis
Huashan Hospital
Observational
300
Shanghai
2020-10-01
Recruiting
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
NCT04528511Atrial Fibrillation New Onset, Acute Myocardial Infarction
Shanghai 10th People's Hospital
Observational
774
Kaifeng, Luoyang, Zhengzhou, Shanghai
2020-10-01
Not yet open
Colorectal Adenoma Canceration in FAP
NCT04531930Familial Adenomatous Polyposis
Changhai Hospital
Observational
124
Shanghai
2020-10-01
Active, closed
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
NCT04524611Crohn's Disease (CD)
AbbVie
Phase 3
527
Hefei, Beijing, Chongqing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Changsha
2020-09-30
Active, closed
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04487080Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
1,074
Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou
2020-09-30
Active, closed
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
NCT04562558Gestational Trophoblastic Tumor, Gestational Trophoblastic Neoplasia, Stage I Gestational Trophoblastic Tumor, Stage II Gestational Trophoblastic Tumor
xiang yang
Not applicable
228
Beijing
2020-09-29
Recruiting
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
NCT04501120Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy
Ascentage Pharma Group Inc.
Phase 1/2
682
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2020-09-28
Rows per page Showing 17801–17900 of 19052
Previous 177 178 179 180 181 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=179

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.